These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On the association between valproate and polycystic ovary syndrome: a response and an alternative view. Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144 [No Abstract] [Full Text] [Related]
4. Valproate and polycystic ovaries. Eberle AJ J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710 [No Abstract] [Full Text] [Related]
7. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Joffe H; Hall JE; Cohen LS; Taylor AE; Baldessarini RJ Harv Rev Psychiatry; 2003; 11(2):99-108. PubMed ID: 12868510 [No Abstract] [Full Text] [Related]
8. Valproate and the polycystic ovarian syndrome: final thoughts. Herzog AG; Schachter SC Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145 [No Abstract] [Full Text] [Related]
9. More on valproate and polycystic ovaries. Johnston HF J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):354. PubMed ID: 10199101 [No Abstract] [Full Text] [Related]
10. [Remission of polycystic ovary syndrome associated with valproic acid in an epileptic female]. Ribacoba-Montero R; Martínez-Faedo C; Díaz-Díaz C; Salas-Puig J Rev Neurol; 2003 Apr 1-15; 36(7):639-42. PubMed ID: 12666045 [TBL] [Abstract][Full Text] [Related]
11. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases. Isojarvi JI; Tapanainen JS Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991 [TBL] [Abstract][Full Text] [Related]
12. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. El-Khayat HA; Abd El-Basset FZ; Tomoum HY; Tohamy SM; Zaky AA; Mohamed MS; Hakky SM; El Barbary NS; Nassef NM Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076 [TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and antiepileptics. Dunn N; Wilton L; Shakir S Lancet; 1999 Sep; 354(9183):1033-4. PubMed ID: 10501393 [No Abstract] [Full Text] [Related]
14. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Morrell MJ; Hayes FJ; Sluss PM; Adams JM; Bhatt M; Ozkara C; Warnock CR; Isojärvi J Ann Neurol; 2008 Aug; 64(2):200-11. PubMed ID: 18756476 [TBL] [Abstract][Full Text] [Related]
15. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries. Soares JC Bipolar Disord; 2000 Mar; 2(1):37-41. PubMed ID: 11254018 [TBL] [Abstract][Full Text] [Related]
16. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324 [TBL] [Abstract][Full Text] [Related]
17. Polycystic ovarian syndrome--relationship to epilepsy and antiepileptic drug therapy. Joffe H; Taylor AE; Hall JE J Clin Endocrinol Metab; 2001 Jul; 86(7):2946-9. PubMed ID: 11443148 [No Abstract] [Full Text] [Related]
18. [Therapy of epilepsy: current strategy and tactics]. Karlov VA Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):28-34. PubMed ID: 15554139 [TBL] [Abstract][Full Text] [Related]
19. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication. Löfgren E; Mikkonen K; Tolonen U; Pakarinen A; Koivunen R; Myllyla VV; Tapanainen JS; Isojärvi JI Epilepsy Behav; 2007 Feb; 10(1):77-83. PubMed ID: 17098479 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy. Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]